OTTAWA, May 21, 2019 /CNW/ - Polish Trade Centre Ltd. is recalling Laskol brand Chrzan from the marketplace because it contains milk which is not declared on the label. People with an allergy to milk should not consume the recalled product described below.
The following product has been sold in Alberta, Manitoba, and Ontario.
Recalled product
Brand
Product
Size
UPC
Codes
Laskol
Chrzan
(Horseradish with citrus acid)
290 g
5 902556 001126
All codes where milk is not declared on the label
What you should do
Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.
If you have an allergy to milk, do not consume the recalled product as it may cause a serious or life-threatening reaction.
This recall was triggered by a consumer complaint. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.
The CFIA is verifying that industry is removing recalled product from the marketplace.
Reactions
There have been no reported reactions associated with the consumption of this product.
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...